BioCentury
ARTICLE | Politics & Policy

Express Scripts offers option to cap insulin costs

April 3, 2019 10:37 PM UTC

As congressional pressure mounts on drug companies and PBMs over rising insulin costs, Express Scripts presented clients with a new option Wednesday that could lessen the burden on patients in the near term.

Express Scripts Holding Co. (NASDAQ:ESRX) clients now have the option to cap their beneficiaries' out-of-pocket costs, including co-pays and deductibles, for insulin products at $25 per month. If employers chose to enroll, the PBM estimates the cap would save beneficiaries 40% compared with an average monthly cost of $41.50 in 2018...